To corroborate with our findings from the patient sample analysis, data from the Microarray Innovations in Leukemia (MILE) study were gathered and stratified to discriminate between PARP1 levels in B-ALL with t(9;22), T-cell ALL, and samples from the bone marrow of healthy donors (Figure 8C). This evidence concerns the gene PARP1 and acute lymphoblastic leukemia.